HR Execs on the Move


 
  • Number of Employees:
  • Annual Revenue:

  • ,

Executives

Name Title Contact Details

Similar Companies

Cabinetworks Group

Cabinetworks Group is a prominent manufacturer and distributor of kitchen and bath cabinets in the United States. As the largest privately held cabinetmaker in the country and the second-largest overall, the company boasts a diverse portfolio of cabinetry brands, including well-known names like KraftMaid, Medallion, Schuler, and Advanta. Their products cater to a wide range of consumers and price points, ensuring options for various needs. The company serves a broad customer base, including kitchen and bath showrooms, builders, architects, and specifiers for multi-family properties. With over 8,000 employees and 18 manufacturing facilities across 24 locations, Cabinetworks Group maintains a strong presence in the market. As a portfolio company of Platinum Equity, it is committed to growth and innovation in the cabinetry sector, while also offering various career opportunities and fostering a culture of community involvement.

NuView Advisors

Your Single Source for all IT & Cybersecurity Solutions NuView Advisors is a group of vCIO/vCTO/vCISO and IT professionals with decades working with organizations of all sizes to standardize IT and Cybersecurity service delivery to the highest standards. Working with NuView is a force multiplier for IT and Cybersecurity departments to focus on higher value strategic activities, streamlining services across existing organizations and helping startups quickly build their IT services for security and scale.

Delinea

Delinea is an ISO 9001:2015 certified CNC manufacturing company which specializes in 3+2 positional and 3 axis precision milling. Founded in 2019 by Vincent and Dan Krische, Delinea is based out of a 4,800 square foot facility in Loveland Colorado. Featuring state-of-the-art equipment and automated software we provide the crucial digital manufacturing service that you need in order to become top of your industry and a leader in innovation.

Swarts, Manning & Associates

Founded in 1996, Swarts, Manning & Associates has quickly established itself as a leader in the insurance industry. As a full-service agency, Swarts, Manning & Associates is dedicated to providing the most comprehensive, customized, and cost-effective insurance solutions available. With specialized departments dedicated to customizing protection for your business, you will partner with an industry expert to assist with your unique risk management needs. Our dedication to customer service and our knowledgeable, friendly staff are just a few of the reasons why Swarts, Manning & Associates stands as a leader and innovator within the insurance industry.

IMUNON

IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.